Northern Trust’s Axcella Health Inc. Common Stock AXLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,047
Closed -$11.2K 4554
2023
Q2
$11.2K Hold
2,047
﹤0.01% 4467
2023
Q1
$24.6K Hold
2,047
﹤0.01% 4409
2022
Q4
$16.8K Buy
2,047
+571
+39% +$14.8K ﹤0.01% 4518
2022
Q3
$63K Buy
1,476
+135
+10% +$7.17K ﹤0.01% 4263
2022
Q2
$68K Hold
1,341
﹤0.01% 4316
2022
Q1
$86K Hold
1,341
﹤0.01% 4394
2021
Q4
$70K Hold
1,341
﹤0.01% 4523
2021
Q3
$100K Sell
1,341
-65
-5% -$5.57K ﹤0.01% 4396
2021
Q2
$141K Sell
1,406
-5,575
-80% -$553K ﹤0.01% 4271
2021
Q1
$831K Sell
6,981
-611
-8% -$86.2K ﹤0.01% 3656
2020
Q4
$985K Buy
7,592
+673
+10% +$86.5K ﹤0.01% 3527
2020
Q3
$800K Buy
6,919
+1,390
+25% +$171K ﹤0.01% 3483
2020
Q2
$764K Buy
5,529
+3,121
+130% +$382K ﹤0.01% 3443
2020
Q1
$206K Buy
2,408
+632
+36% +$64.8K ﹤0.01% 3678
2019
Q4
$178K Buy
1,776
+596
+51% +$65.5K ﹤0.01% 3815
2019
Q3
$167K Buy
1,180
+795
+206% +$147K ﹤0.01% 3804
2019
Q2
$90K Buy
+385
New +$122K ﹤0.01% 3990

Other funds holding AXLA

Northern Trust's AXLA Position: Q3 2023 in Review

Northern Trust sold out of Axcella Health Inc. Common Stock (AXLA) in Q3 2023, closing a stake of 2,047 shares — an estimated $11.2K sold.

Northern Trust first reported a position in AXLA in Q2 2019 and held it in 17 quarters. The position peaked at $985K in Q4 2020. 15 funds tracked by Wall St. Rank hold AXLA as of Q3 2023.

  • Northern Trust reported no remaining Axcella Health Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Northern Trust sold 2,047 Axcella Health Inc. Common Stock shares in Q3 2023, an estimated $11.2K.
  • Northern Trust first reported a position in Axcella Health Inc. Common Stock in Q2 2019 and held it in 17 quarters.
  • Northern Trust's Axcella Health Inc. Common Stock position peaked at $985K in Q4 2020.
  • 15 funds tracked by Wall St. Rank held Axcella Health Inc. Common Stock as of Q3 2023.

Based on Northern Trust's 13F filing for Q3 2023, filed 13 Nov 2023.